Together, these findings substantiate a COX-2-PGE2-MMP-9 link across cancer, arthritis, and myeloid models and highlight NSAIDs potential to mitigate tissue destruction by halting prostaglandin-driven gelatinase activity. Here, MMP9 is linked to arthritic joint disease.